Risk Factors of Sternal Wound Infection After Coronary Artery Bypass Graft

July 8, 2014 updated by: Sangmin M. Lee, Samsung Medical Center
The investigators are trying to evaluate the performance of neutrophil and lymphocyte counts as a risk factor of deep sternal wound infection after coronary artery bypass graft surgery.

Study Overview

Detailed Description

Deep sternal wound infection after coronary artery bypass graft is a very dangerous complication as it prolongs hospital stay, increase morbidity and mortality, and increase cost of care.

As a risk factor of surgical site infection, risk index reported by NNIS (national nosocomial infection surveillance), Euroscore, or Society of thoracic surgeon risk score are currently used. However, as various performances are reported regarding these index or scoring systems, and many factors are needed for these index or scoring system, there is a need to develop a more simple risk factor with better performance. We focused on the differential blood cell count, as the neutrophil and lymphocyte count are related to the degree of surgical invasion, and inflammatory response. Previous studies reported that the neutrophilia or lymphopenia is related to postoperative infection. Therefore, we are trying to evaluate the performance of preoperative or postoperative the blood cell differential count as a risk factor for sternal wound infection after coronary artery bypass surgery.

Study Type

Observational

Enrollment (Anticipated)

1850

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Seoul, Korea, Republic of, 135-710
        • Recruiting
        • Samsung Medical Center
        • Sub-Investigator:
          • Sangmin M. Lee, MD, PhD
        • Sub-Investigator:
          • Young Tak Lee, MD, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 90 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Those underwent coronary artery bypass graft surgery with median sternotomy in Samsung Medical Center during the period of January 2008 and December 2011.

Description

Inclusion Criteria:

  • Those underwent coronary artery bypass graft surgery with median sternotomy in Samsung Medical Center during the period of January 2008 and December 2011.

Exclusion Criteria:

  • Those underwent coronary artery bypass graft surgery with mini-thoracotomy
  • Those with insufficient study data recognized by electronic medical record

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Coronary Artery Bypass Graft Group
Those underwent coronary artery bypass graft surgery with median sternotomy in Samsung Medical Center during the period of January 2008 and December 2011.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
postoperative surgical wound infection
Time Frame: within first week after the end of coronary artery bypass graft surgery
postoperative surgical wound infection within first week after the end of coronary artery bypass graft surgery, classified as a superfical or deep sternal wound infection
within first week after the end of coronary artery bypass graft surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
preoperative total leukocyte count
Time Frame: 1 day before surgery
preoperative total leukocyte count
1 day before surgery
preoperative neutrophil count
Time Frame: 1 day before surgery
preoperative neutrophil count
1 day before surgery
preoperative lymphocyte count
Time Frame: 1 day before surgery
preoperative lymphocyte count
1 day before surgery
postoperative total leukocyte count
Time Frame: 2 hour after the end of surgery
postoprative total leukocyte count
2 hour after the end of surgery
postoperative neutrophil count
Time Frame: 2 hour after the end of surgery
postoperative neutrophil count
2 hour after the end of surgery
postoperative lymphocyte count
Time Frame: 2 hour after the end of surgery
postoperative lymphocyte count
2 hour after the end of surgery
preoperative NNIS risk index
Time Frame: 1 day before surgery
preoperative NNIS risk index
1 day before surgery
preoperative EuroScore
Time Frame: 1 day before surgery
preoperative EuroScore
1 day before surgery
Preoperative STS
Time Frame: 1 day before surgery
Preoperative STS (Society of Thoracic Surgeons risk score)
1 day before surgery
the incidence of surgical reopen with surgical wound infection
Time Frame: within 1 month after surgery
the incidence of surgical reopen with surgical wound infection
within 1 month after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Won Ho Kim, MD, PhD, Samsung Medical Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2012

Primary Completion (Anticipated)

December 1, 2014

Study Completion (Anticipated)

December 1, 2014

Study Registration Dates

First Submitted

June 25, 2012

First Submitted That Met QC Criteria

June 26, 2012

First Posted (Estimate)

June 27, 2012

Study Record Updates

Last Update Posted (Estimate)

July 9, 2014

Last Update Submitted That Met QC Criteria

July 8, 2014

Last Verified

July 1, 2014

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2012-05-067-001

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Coronary Artery Bypass Graft

3
Subscribe